These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16265070)

  • 61. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.
    Fung SK; Lok AS
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):90-7. PubMed ID: 16265070
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A review of entecavir in the treatment of chronic hepatitis B infection.
    Rivkin A
    Curr Med Res Opin; 2005 Nov; 21(11):1845-56. PubMed ID: 16307706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Entecavir for chronic hepatitis B: a review.
    Palumbo E
    Ther Drug Monit; 2008 Feb; 30(1):1-4. PubMed ID: 18223455
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW; Chen YG
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of chronic hepatitis B.
    Mohanty SR; Kupfer SS; Khiani V
    Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):446-58. PubMed ID: 16883349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapy of chronic hepatitis B: trends and developments.
    Delaney WE; Borroto-Esoda K
    Curr Opin Pharmacol; 2008 Oct; 8(5):532-40. PubMed ID: 18835366
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
    Lok AS; Zoulim F; Locarnini S; Bartholomeusz A; Ghany MG; Pawlotsky JM; Liaw YF; Mizokami M; Kuiken C;
    Hepatology; 2007 Jul; 46(1):254-65. PubMed ID: 17596850
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of drug-resistant chronic hepatitis B.
    Fung SK; Fontana RJ
    Clin Liver Dis; 2006 May; 10(2):275-302, viii. PubMed ID: 16971262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Entecavir: a new treatment option for chronic hepatitis B.
    Zoulim F
    J Clin Virol; 2006 May; 36(1):8-12. PubMed ID: 16515882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nucleotide analogs as novel anti-hepatitis B virus agents.
    Iyer RP; Padmanabhan S; Zhang G; Morrey JD; Korba BE
    Curr Opin Pharmacol; 2005 Oct; 5(5):520-8. PubMed ID: 16087397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
    Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of HBeAg-positive patients with nucleos/tide analogues.
    Coffin CS; Lee SS
    Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current pharmacotherapy for hepatitis B infection.
    Galan MV; Boyce D; Gordon SC
    Expert Opin Pharmacother; 2001 Aug; 2(8):1289-98. PubMed ID: 11584997
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.